Transforming growth factor-β1 induces matrix metalloproteinase-9 expression in rat vascular smooth muscle cells via ROS-dependent ERK-NF-κB pathways

Molecular and Cellular Biochemistry

Volumn 375, Issue 1-2, 2013, Pages 11-21

  Zhang, Hao ^a,b   Wang, Zhi Wei ^a   Wu, Hong Bing ^a   Li, Zhi ^b   Li, Luo Cheng ^a   Hu, Xiao Ping ^a   Ren, Zong Li ^a   Li, Bai Jun ^a   Hu, Zhi Peng ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Xiangyang Central Hospital   (China)

Author keywords

ERK; MMP9; NF B; ROS; TGF 1; VSMC

Indexed keywords

ACETYLCYSTEINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; AORTA ANEURYSM; AORTA DISSECTION; ARTICLE; ENZYME ACTIVATION; GENE ACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CELL LINE; ENZYME INDUCTION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 84873059061     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1512-7     Document Type: Article

References (41)

1. Borges LF, Touat Z, Leclercq A, Zen AA, Jondeau' G, Franc B, Philippe M, Meilhac O, Gutierrez PS, Michel JB (2009) Tissue diffusion and retention of metalloproteinases in ascending aortic aneurysms and dissections. Hum Pathol 40:306-313
2. Allaire E, Schneider F, Saucy F, Dai J, Cochennec F, Michineau S, Zidi M, Becquemin JP, Kirsch M, Gervais M (2009) New insight in aetiopathogenesis of aortic diseases. Eur J Vasc Endovasc Surg 37:531-537
3. Wilson WR, Anderton M, Schwalbe EC, Jones JL, Furness PN, Bell PR, Thompson MM (2006) Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 113:438-445
4. ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857-869
5. Goumans MJ, Liu Z, ten DP (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Res 19:116-127
6. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407-411
7. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B (2008) Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 358:2787-2795
8. Habashi JP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117-121
9. Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys BL, Thomas CJ, Patnaik S, Marugan JJ, Judge DP, Dietz HC (2011) Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332:358-361
10. Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 108:2034-2040
11. Taniyama Y, Griendling KK (2003) Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42:1075-1081
12. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, Hoshii Y, Tanaka N, Ricci R, Ishihara T, Esato K, Hamano K, Matsuzaki M (2005) Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 11:1330-1338
13. Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S, Libby P, MacFarlane LA, Mallen-St Clair J, Shi GP (2007) Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13:719-724
14. Thomas M, Gavrila D, McCormick ML, Miller FJ Jr, Daugherty A, Cassis LA, Dellsperger KC, Weintraub NL (2006) Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysmformation in apolipoprotein E-deficient mice. Circulation 114:404-413
15. Gavazzi G, Deffert C, Trocme C, Schappi M, Herrmann FR, Krause KH (2007) NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 50:189-196
16. Chung AW, Yang HH, Radomski MW, van BC (2008) Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 102:e73-e85
17. Clempus RE, Griendling KK (2006) Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 71:216-225
18. Ghosh A, Dimusto PD, Ehrlichman LK, Sadiq O, McEvoy B, Futchko JS, Henke PK, Eliason JL, Upchurch GR Jr (2012) The role of extracellular signal-related kinase during abdominal aortic aneurysm formation. J Am Coll Surg 215(5):668-680
19. Habashi JP, Doyle JJ, Holm TM, Aziz H, Schoenhoff F, Bedja D, Chen Y, Modiri AN, Judge DP, Dietz HC (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332:361-365
20. Mi T, Nie B, Zhang C, Zhou H (2011) The elevated expression of osteopontin and NF-kappaB in human aortic aneurysms and its implication. J Huazhong Univ Sci Technol Med Sci 31:602-607
21. Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M, Jo N, Oishi M, Kataoka K, Ohgi S, Ogihara T, Kaneda Y, Morishita R (2004) Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoyoligodeoxynucleotides suppressing activity of nuclear factor kappaB and etstranscription factors. Circulation 109:132-138
22. Sun L, Diamond ME, Ottaviano AJ, Joseph MJ, Ananthanarayan V, Munshi HG (2008) Transforming growth factor-beta 1 promotes matrix metalloproteinase-9- mediated oral cancer invasion through snail expression. Mol Cancer Res 6:10-20
23. Okamoto T, Takahashi S, Nakamura E, Nagaya K, Hayashi T, Fujieda K (2009) Transforming growth factor-beta1 induces matrix metalloproteinase-9 expression in human meningeal cells via ERK and Smad pathways. Biochem Biophys Res Commun 383:475-479
24. Ishikawa F, Miyoshi H, Nose K, Shibanuma M (2010) Transcriptional induction of MMP-10 by TGF-beta, mediated by activation of MEF2A and downregulation of class IIa HDACs. Oncogene 29:909-919
25. Ikonomidis JS, Jones JA, Barbour JR, Stroud RE, Clark LL, Kaplan BS, Zeeshan A, Bavaria JE, Gorman JH III, Spinale FG, Gorman RC (2006) Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation 114:I365-I370
26. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355:788-798
27. Wang X, LeMaire SA, Chen L, Shen YH, Gan Y, Bartsch H, Carter SA, Utama B, Ou H, Coselli JS, Wang XL (2006) Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation 114:I200-I205
28. Grond-Ginsbach C, Pjontek R, Aksay SS, Hyhlik-Durr A, Bockler D, Gross-Weissmann ML (2010) Spontaneous arterial dissection: phenotype and molecular pathogenesis. Cell Mol Life Sci 67:1799-1815
29. Lesauskaite V, Tanganelli P, Sassi C, Neri E, Diciolla F, Ivanoviene L, Epistolato MC, Lalinga AV, Alessandrini C, Spina D (2001) Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol 32:1003-1011
30. Zhang Q, Huang JH, Xia RP, Duan XH, Jiang YB, Jiang Q, Sun WJ (2011) Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol. J Surg Res 167:e385-e393
31. Morimoto K, Hasegawa T, Tanaka A, Wulan B, Yu J, Morimoto N, Okita Y, Okada K (2012) Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. J Vasc Surg 55:1749-1758
32. Binker MG, Binker-Cosen AA, Gaisano HY, de Cosen RH, Cosen-Binker LI (2011) TGF-beta1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-kappaB/IL-6/MMP-2. Biochem Biophys Res Commun 405:140-145
33. Koli K, Myllarniemi M, Keski-Oja J, Kinnula VL (2008) Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 10:333-342
34. Wu WS (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25:695-705
35. Olieslagers S, Pardali E, Tchaikovski V, ten Dijke P, Waltenberger J (2011) TGF-beta1/ALK5-induced monocyte migration involves PI3 K and p38 pathways and is not negatively affected by diabetes mellitus. Cardiovasc Res 91:510-518
36. Akool el-S, Gauer S, Osman B, Doller A, Schulz S, Geiger H, Pfeilschifter J, Eberhardt W (2012) Cyclosporin A and tacrolimus induce renal Erk1/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling. Biochem Pharmacol 83:286-295
37. Tobar N, Villar V, Santibanez JF (2010) ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem 340:195-202
38. Kam AY, Liu AM, Wong YH (2007) Formyl peptide-receptor like-1 requires lipid raft and extracellular signal-regulated protein kinase to activate inhibitor-kappa B kinase in human U87 astrocytoma cells. J Neurochem 103:1553-1566
39. Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, Sonenshein GE (2003) Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 22:412-425
40. Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Terao T (2004) Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem 279:8567-8576
41. Zhu Y, Culmsee C, Klumpp S, Krieglstein J (2004) Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience 123:897-906